{ }
001122334455554433221100
001122334455554433221100

versant launches pep2tango to develop innovative multi-target obesity drug

Versant Ventures has launched Pep2Tango Therapeutics, aiming to create a groundbreaking obesity drug that combines four treatment mechanisms: GLP-1, GIP, amylin, and calcitonin receptors. The startup claims its approach could lead to greater efficacy and reduced muscle loss compared to existing therapies. With significant market potential, Pep2Tango's innovative strategy reflects a shift towards multi-target solutions in obesity treatment.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.